Lataa...
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer
There is firm evidence that PSA velocity is statistically associated with many prostate cancer outcomes, including those related to early detection. But clinical use of a marker depends on clinical as well as statistical significance. Before using PSA velocity to inform decisions such as whether or...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4054698/ https://ncbi.nlm.nih.gov/pubmed/23486455 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|